Eivind Hovig

17.0k total citations · 4 hit papers
218 papers, 8.9k citations indexed

About

Eivind Hovig is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Eivind Hovig has authored 218 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Molecular Biology, 60 papers in Cancer Research and 47 papers in Oncology. Recurrent topics in Eivind Hovig's work include Cancer Genomics and Diagnostics (44 papers), Gene expression and cancer classification (30 papers) and Molecular Biology Techniques and Applications (23 papers). Eivind Hovig is often cited by papers focused on Cancer Genomics and Diagnostics (44 papers), Gene expression and cancer classification (30 papers) and Molecular Biology Techniques and Applications (23 papers). Eivind Hovig collaborates with scholars based in Norway, United States and Sweden. Eivind Hovig's co-authors include Astrid Lægreid, Jan Komorowski, Birgitte Smith‐Sørensen, Tor‐Kristian Jenssen, Ola Myklebost, Øystein Fodstad, Geir Kjetil Sandve, Gunhild M. Mælandsmo, Monica Hollstein and C C Harris and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

Eivind Hovig

214 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Database of p53 gene somatic mutations in human tumors and cell lines.

1994 727 citations Eivind Hovig et al. PubMed profile →
A literature network of human genes for high-throughput analysis of gene expression.

2001 581 citations Eivind Hovig et al. profile →
Ten Simple Rules for Reproducible Computational Research

2013 418 citations Geir Kjetil Sandve, Eivind Hovig et al. profile →
JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles

2023 334 citations Morten Johansen, Eivind Hovig et al. Nucleic Acids Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eivind Hovig Norway	46	6.0k	2.3k	2.2k	1.1k	781	218	8.9k
Jeffrey T. Chang United States	38	6.6k 1.1×	1.6k 0.7×	1.5k 0.7×	888 0.8×	657 0.8×	109	9.5k
Matthew J. Marton United States	18	7.5k 1.3×	2.8k 1.2×	2.5k 1.1×	1.4k 1.2×	767 1.0×	45	10.6k
Alexander D. Borowsky United States	51	4.7k 0.8×	1.6k 0.7×	2.6k 1.2×	663 0.6×	1.3k 1.6×	197	8.7k
Mao Mao United States	37	8.6k 1.4×	3.6k 1.6×	2.8k 1.3×	1.5k 1.3×	1.1k 1.4×	108	13.5k
Garret M. Hampton United States	45	5.6k 0.9×	1.9k 0.8×	2.6k 1.2×	975 0.9×	1.2k 1.6×	93	9.1k
Kai Ye China	45	5.1k 0.8×	2.4k 1.0×	1.6k 0.7×	1.9k 1.7×	845 1.1×	190	10.8k
William C. Reinhold United States	48	7.5k 1.3×	2.3k 1.0×	2.6k 1.2×	652 0.6×	897 1.1×	114	10.2k
Hongyue Dai United States	34	9.3k 1.6×	4.4k 1.9×	3.4k 1.5×	1.5k 1.3×	1.1k 1.4×	66	14.2k
Rork Kuick United States	56	7.8k 1.3×	3.4k 1.5×	2.4k 1.1×	1.4k 1.2×	1.2k 1.6×	156	13.0k
Tim Beißbarth Germany	46	5.0k 0.8×	1.8k 0.8×	3.3k 1.5×	601 0.5×	1.1k 1.4×	227	10.3k

Countries citing papers authored by Eivind Hovig

Since Specialization

Citations

This map shows the geographic impact of Eivind Hovig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eivind Hovig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eivind Hovig more than expected).

Fields of papers citing papers by Eivind Hovig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eivind Hovig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eivind Hovig. The network helps show where Eivind Hovig may publish in the future.

Co-authorship network of co-authors of Eivind Hovig

This figure shows the co-authorship network connecting the top 25 collaborators of Eivind Hovig. A scholar is included among the top collaborators of Eivind Hovig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eivind Hovig. Eivind Hovig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hovig, Eivind, et al.. (2026). ‘Crossing borders’ in data standardisation: application of OMOP CDM in an international clinical trial network in precision cancer medicine. Acta Oncologica. 65. 159–163.

Møller, Pål, Aysel Ahadova, Matthias Kloor, et al.. (2025). Colorectal carcinogenesis in the Lynch syndromes and familial adenomatous polyposis: trigger events and downstream consequences. Hereditary Cancer in Clinical Practice. 23(1). 3–3. 1 indexed citations

Royo, Romina, Eva G. Álvarez, Irene Schlünder, et al.. (2025). Genomic data sharing in research across Europe: legal challenges and upcoming opportunities within the European Health Data Space. European Journal of Public Health. 35(Supplement_3). iii25–iii31. 1 indexed citations

Edsjö, Anders, Hege G. Russnes, Janne Lehtiö, et al.. (2024). High‐throughput molecular assays for inclusion in personalised oncology trials – State‐of‐the‐art and beyond. Journal of Internal Medicine. 295(6). 785–803. 5 indexed citations

Nikolski, Macha, Eivind Hovig, Fátima Al‐Shahrour, et al.. (2024). Roadmap for a European cancer data management and precision medicine infrastructure. Nature Cancer. 5(3). 367–372. 3 indexed citations

Billingham, Lucinda, Theodor Framke, Alastair Greystoke, et al.. (2023). Histology independent drug development – Is this the future for cancer drugs?. Cancer Treatment Reviews. 123. 102674–102674. 1 indexed citations

Misund, Kristine, Davine Hofste op Bruinink, Eivind Coward, et al.. (2022). Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence. Leukemia. 36(7). 1887–1897. 34 indexed citations

Deng, Wei, Jürgen Geisler, Stephanie Geisler, et al.. (2022). Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy. Genome Medicine. 14(1). 86–86. 10 indexed citations

Bazo‐Alvarez, Juan Carlos, Patrik Wernhoff, Per Olaf Ekstrøm, et al.. (2022). Genetic Characterization in High-Risk Individuals from a Low-Resource City of Peru. Cancers. 14(22). 5603–5603. 1 indexed citations

10.

Høye, Eirik, Bastian Fromm, P. H. Michael Böttger, et al.. (2022). A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancer. NAR Cancer. 4(1). zcab051–zcab051. 9 indexed citations

11.

Fromm, Bastian, Eirik Høye, Diana Domańska, et al.. (2021). MirGeneDB 2.1: toward a complete sampling of all major animal phyla. Nucleic Acids Research. 50(D1). D204–D210. 90 indexed citations

12.

Pace, Marta, Andrea Freschi, Chiara Berteotti, et al.. (2020). Loss of Snord116 impacts lateral hypothalamus, sleep, and food-related behaviors. JCI Insight. 5(12). 22 indexed citations

13.

Ree, Anne Hansen, Vigdis Nygaard, Hege G. Russnes, et al.. (2019). Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number Gain. Cancer Immunology Research. 7(5). 701–706. 5 indexed citations

14.

Fromm, Bastian, Diana Domańska, Eirik Høye, et al.. (2019). MirGeneDB 2.0: the metazoan microRNA complement. Nucleic Acids Research. 48(D1). D132–D141. 179 indexed citations

15.

Tolios, Alexander, Javier De Las Rivas, Eivind Hovig, et al.. (2019). Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions. Drug Resistance Updates. 48. 100662–100662. 47 indexed citations

16.

Nakken, Sigve, et al.. (2017). Personal Cancer Genome Reporter: variant interpretation report for precision oncology. Bioinformatics. 34(10). 1778–1780. 31 indexed citations

17.

Wibom, Carl, Anna M. Dahlin, Hilde Langseth, et al.. (2015). Investigation of Established Genetic Risk Variants for Glioma in Prediagnostic Samples from a Population-Based Nested Case–Control Study. Cancer Epidemiology Biomarkers & Prevention. 24(5). 810–816. 15 indexed citations

18.

Paulsen, Jonas, Tonje G. Lien, Geir Kjetil Sandve, et al.. (2013). Handling realistic assumptions in hypothesis testing of 3D co-localization of genomic elements. Nucleic Acids Research. 41(10). 5164–5174. 18 indexed citations

19.

Nakken, Sigve, Einar Andreas Rødland, Torbjørn Rognes, & Eivind Hovig. (2009). Large-scale inference of the point mutational spectrum in human segmental duplications. BMC Genomics. 10(1). 43–43. 7 indexed citations

20.

Ree, Anne Hansen, Olav Engebraaten, Marianne Rooman, et al.. (1999). Expression of a novel factor in human breast cancer cells with metastatic potential.. PubMed. 59(18). 4675–80. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact